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Dear Editor, 
  In their article, Fortún et al. [1] found higher CA-125 
serum levels in patients with pulmonary tuberculosis than in 
other lung infections and concluded that this tumor marker is 
useful for the diagnosis of tuberculosis. There are, however, 
some points of concern in that study. 
  A major point is the effect of pleural involvement. In 
diseases with pleural, pericardial or peritoneal involvement 
increases in CA-125 are almost constant, because this 
antigen is present in mesothelial cells of these structures, 
especially in areas of inflammation [2].  Benign serous 
effusions, particularly ascites, are associated with increased 
serum concentrations of CA-125, reaching very high values 
of up to 100 times the normal limit [3-7]. In fact, CA-125 
has proved to be an excellent marker for ascites in patients 
with benign liver diseases (sensitivity 98%, specificity 96%, 
positive predictive value 94%, negative predictive value 
99%, efficiency 97%) [3]. Therefore, whenever serous 
effusion of any etiology is present, CA-125 is expected to be 
substantially elevated, losing its diagnostic value. 
  Although the proportion of patients with pleural effusion 
was similar in the control and tuberculosis groups in the 
authors’ study (14.8% and 11.4%, respectively), no 
information is provided about the estimated amount of 
pleural fluid. This aspect is important because CA-125 is 
very sensitive to minimal amounts of ascites and correlates 
very well with the amount of ascitic fluid, decreasing rapidly 
following therapy and even predicting the recurrence of 
ascites [3, 8]. 
  The authors do not provide information about the 
individual CA-125 values, but the means, SD and medians 
clearly indicate that the distribution was markedly non-
Gaussian, particularly in the tuberculosis group. In fact, the 
range of CA-125 values in this group multiplied by 50. 
Therefore, considering the sensitivity of this marker and its 
strong relationship with the amount of fluid, the results could 
have been biased towards the patients with greater pleural 
effusions. 
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  Moreover, the authors state that the Mantel-Haenszel test 
was used to compare continuous variables. However, this 
test contrasts categorical variables. Therefore, it is not clear 
which test was actually used, but given the marked non-
Gaussian distribution of CA-125, if parametric tests had 
been used to assess the differences in CA-125 levels, their 
results would not have been reliable. 
  Also, the alleged conclusion about the usefulness of CA-
125 in tuberculosis patients with negative sputum smears did 
not derive from the study, because all but one of the patients 
had positive sputum smears, which represented a quicker and 
much more reliable procedure than CA-125 for the diagnosis 
of tuberculosis in this series. Moreover, the limited yield of 
sputum smears in tuberculosis, and the association of 
positive smears with extensive disease, suggest that these 
patients had advanced disease, biasing additionally the 
results. 
  Finally, the decrease in CA-125 levels following therapy 
reported by the authors is not unexpected, as the pleural fluid 
and inflammation disappeared. Decreases in other markers 
have also been described in patients receiving successful 
treatment for tuberculosis [9, 10]. 
  Therefore, the impact of pleural effusion on the results 
was presumably substantial. In addition, the control group 
was hardly comparable, because tuberculosis patients have 
usually more extensive disease than other lung infections, 
particularly in HIV-infected patients, who were also 
misbalanced between the two groups, and conditions such as 
exacerbated COPD should not be compared with 
tuberculosis for this purpose (even in 12 control patients 
there were no infiltrates). To evaluate the real value of CA-
125 in tuberculosis diagnosis, only patients without pleural 
effusion, even in minimal amounts, and with comparable 
conditions (i.e. extensive pneumonia) should have been 
considered, because this marker losses its value in patients 
with serous effusions, as it reflects the existence and amount 
of effusion and pleural involvement rather than the 
underlying disease. 
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